Articles

Find an Article

Filter articles

Applied Filters

Showing 841 to 850 of 945 results

Patenting life

EPO, EU01-01-2011Biotech Directive, BiotechnologyAshley Roughton

A case before the Court of Justice for the European Union threatens to radically redraw the patent landscape for embryonic stem cells. Ashley Roughton explains.

Online issues at the ECJ

EU, Poland01-01-2011Anna Szajna and Maria Jurek

Since Poland’s accession to the EU, judgments of the Court of Justice of the European Union (ECJ) have been part of the Polish law and are applied directly with priority to national law. Anna Szajna and Maria Jurek take a look at the key cases.

AIPPI, Palais des Congrès, Paris

EPO01-12-2010

The 42nd AIPPI Intellectual Property Congress featured contributions from some of the most influential figures in IP and a lively debate among senior judges on the scope of patentability across jurisdictions.

CIPA, The Lancaster London Hotel, London

01-12-2010

Patent attorneys amassed at a London hotel to talk IP of the past decade and the next. WIPR looks at the highlights.

Judging dread: what is the EEUPC?

EU01-12-2010

IP is a booming business these days, and Europe’s myriad personalities are seen as a hindrance to cheap and effective patent protection. A European patent is obtainable, but enforcement is riddled with practical problems.

Consumers first: GlaxoSmithKline on trademarks

01-12-2010

People often think that IP in the healthcare sector is all about patents. But while GlaxoSmithKline certainly has a patent portfolio to protect, it also takes a strident approach to enforcing its trademarks and defending its brands.

Back to basics: renewing the foundations of innovation

US01-12-2010BiotechnologyJim Greenwood

The economic crisis has caused companies and governments alike to reassess their spending. Jim Greenwood explains why imperilling IP protection for the biotechnology industry would be the worst possible outcome.

ANDA one, ANDA too?

US01-12-2010David K.S. Cornwell and Kevin W. McCabe

David Cornwell and Kevin McCabe describe the complex process for obtaining FDA approval for generic and biosimilar drugs, and managing patent disputes with approved companies.

Will the future of gene patents be "markedly different" after Myriad?

US01-12-2010BiotechnologyLee Crews and Vicki Norton

A US district court decision threatens the future of so-called ‘gene patents’ in the US. Lee Crews and Vicki Norton look at the current position and assess the possible futures for the case.

Counterfeit medicines - the quintessential borderless crime

01-12-2010

The global spread of counterfeit pharmaceuticals presents a formidable challenge to public health. WIPR asked lawyers from Baker & McKenzie offices around the world about this growing menace and what IP rights owners can do.

Showing 841 to 850 of 945 results

Directory

Service Providers

Park IP Translations
Park IP is your trusted partner for legal language solutions

WIPR